Circulating Tumor Cells in Patients with Breast Cancer Dormancy
By S. Meng, D. Tripathy, E. Frenkel, S. Shete, E. Naftalis, J. Huth, P. Beitsch, M. Leitch, S. Hoover, D. Euhus and 10 more. Clinical Cancer Research, 2004
949 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/cc425e7fb530588c8ca1458f61b8517a70d0782a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- K. Pantel
- J. Aguirre-Ghiso
- Ruud H. Brakenhoff
- J. Tsai
- Jing Yang
- B. Brandt
- C. Alix‐Panabières
- A. Ullrich
In Oncology
- Jing Yang
- J. Aguirre-Ghiso
- K. Pantel
- Ruud H. Brakenhoff
- John N. Weinstein
- J. Ludwig
- J. Tsai
- B. Brandt
Citations in the corpus
- Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. (2012, background): “Cancer patients can develop metastases from dormant tumor cells years after primary tumor resection (Chambers et al., 2002; Goss and Chambers, 2010; Meng et al., 2004).”
- Detection, clinical relevance and specific biological properties of disseminating tumour cells (2008, background): “The fact that tumour cells are detectable in the peripheral blood of patients with breast cancer months to years after complete removal of the primary tumour indicates that these cells might re-circulate between metastatic site”
- Biomarkers in Cancer Staging, Prognosis and Treatment Selection (2005, background): “as indicators of systemic metastasis, but the clinical sample sizes have been small and the long-term survival benefit remains to be assesse”
- Metronomic chemotherapy: new rationale for new directions (2010, background): “For instance, in some extreme cases, circulating tumor cells can be found more than 20 years after mastectomy in patients who were without evidence of disease”
- Models, mechanisms and clinical evidence for cancer dormancy (2007, background): “Characterization of disseminated tumour cells has proven to be extremely difficult because of their low abundance (1 disseminated tumour cell per 10 6 bone marrow cells and 1–2 disseminated tumour cells per 20 ml of blood”
- Tumor Metastasis: Molecular Insights and Evolving Paradigms (2011, neutral): “This explains why > 90% of mortality from cancer is attributable to metastases, not the primary tumors from which these malignant lesions arise (Gupta and Massagué, 2006; Steeg, 2006).”